| Product Name | MF | CAS | Details |
|---|
| Cilostazol Related Compound C | C31H45N9O2 | 865792-18-3 | Details |
| GSK 962040 | C25H33FN4O | 923565-21-3 | Details |
| 1-(4-tert-Butylphenyl)ethanamine HCl | C12H20ClN | 91552-71-5 | Details |
| p-Phenetidine | C8H11NO | 156-43-4 | Details |
| 4'-Hydroxy aceclofenac | C16H13Cl2NO5 | 229308-90-1 | Details |
| 1-Methyl-1H-pyrazolo[3,4-c]pyridin-3-amine | C7H8N4 | 1557979-67-5 | Details |
| (S)-Rexamino | C9H10N2O | 165035-65-4 | Details |
| 6-Cyclopropyl-1-(thiophen-3-ylmethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid | C15H13N3O2S | 954579-22-7 | Details |
| F13B antibody | Details |
| 2-(5-chlorobenzo[b]thiophen-3-yl)acetic acid | C10H7ClO2S | 17266-30-7 | Details |
| Neocarrahexaose-41,3,5-tri-O-sulfate sodium salt | C36H53Na3O37S3 | 133628-76-9 | Details |
| N-Cyclobutyl-4-fluoroaniline hydrochloride | C10H13ClFN | 2228694-06-0 | Details |
| (6-Chloro-2,3-difluorophenyl)boronic acid | C6H4BClF2O2 | 1310404-70-6 | Details |
| 2-(2,4-Dichlorophenoxy)ethanol | C8H8Cl2O2 | 120-67-2 | Details |
| 1-(3-Bromocyclopentyl)-3,5-difluorobenzene | C11H11BrF2 | 1343646-08-1 | Details |
| LIMD2 protein (His tag) | Details |
| [5-Chloro-1-(propan-2-yl)-1H-1,3-benzodiazol-2-yl]methanol | C11H13ClN2O | 1243821-91-1 | Details |
| Durantoside II | C27H34O14 | 53526-66-2 | Details |
| 2-(Boc-amino)-3-methylpyridine | C11H16N2O2 | 138343-75-6 | Details |
| Cryptanoside A | C30H42O10 | 98570-81-1 | Details |
| PLOD2 antibody | Details |
| VTI1A antibody | Details |
| CDC23 Blocking Peptide | Details |
| 1-Methyl-1H,4H,6H,7H-pyrano[4,3-c]pyrazole-3-carboxylic acid | C8H10N2O3 | 1533231-78-5 | Details |
| 2,3-Dimethyl-5H,6H,7H,8H-imidazo[1,2-a]pyrazine | C8H13N3 | 1250515-54-8 | Details |
| 4-bromonaphthalene-2-carbaldehyde | C11H7BrO | 874357-11-6 | Details |
| 5-Fluorouridine | C9H11FN2O6 | 316-46-1 | Details |
| Erk1/2 inhibitor 2 | C29H31ClFN5O5 | 2095719-92-7 | Details |
| 3'-Fluoro-4'-methoxyacetophenone | C9H9FO2 | 455-91-4 | Details |
| (3-Amino-1,1,1-trifluoropropan-2-yl)(benzyl)amine | C10H13F3N2 | 270253-11-7 | Details |
| 2-N-(2,4,6-Trimethylphenyl)pyridine-2,3-diamine | C14H17N3 | 444325-84-2 | Details |
| PAP antibody | Details |
| TP53INP2 antibody | Details |
| 3,5-Di-O-toluoyl 6-chloropurine-7-b-D-deoxyriboside | C26H23ClN4O5 | 91713-51-8 | Details |
| 7-Acetyl-6-bromo-3,4-dihydro-2H-1,4-benzoxazin-3-one | C10H8BrNO3 | 1152582-08-5 | Details |
| DTX3L antibody | Details |
| Ac-NNN-NH2 | Details |
| 4-Nitrophenyl 2-O-trans-feruloyl-a-L-arabinofuranoside | C21H21NO10 | 508220-80-2 | Details |
| 4-Nitrophenyl 2,3,4,6-tetra-O-acetyl-b-D-glucopyranoside | C20H23NO12 | 5987-78-0 | Details |
| 2,3,5-Tri-O-acetyl α-adenosine | C16H19N5O7 | 953089-09-3 | Details |
| 14-Hydroxy sprengerinin C | C44H70O17 | 1111088-89-1 | Details |
| 2-(1-Methyl-1H-indol-2-yl)ethan-1-ol | C11H13NO | 57666-13-4 | Details |
| DM4-SMe | C39H56ClN3O10S2 | 796073-68-2 | Details |
| (3,4-diphenyl(2,5-thiazolyl))(4-(trifluoromethoxy)phenyl)amine | C22H15F3N2OS | 798558-42-6 | Details |
| Goat anti Canine IgE | Details |
| ML-180 | C20H25ClN4O2 | 863588-32-3 | Details |
| APL1b25 trifluoroacetate salt | C98H166N28O35S | 1233876-43-1 | Details |
| 2-(Bromomethyl)-5-fluoropyridine hydrobromide | C6H6Br2FN | 1186194-88-6 | Details |
| 2-{4-[(tert-Butoxy)carbonyl]-6-methylmorpholin-2-yl}acetic acid | C12H21NO5 | 2167070-91-7 | Details |
| (3S)-3-({[(tert-Butoxy)carbonyl]amino}methyl)-5-methylhexanoic acid | C13H25NO4 | 649748-09-4 | Details |
| H-Pro-Lys-OH acetate salt | C11H21N3O3 | 71227-70-8 | Details |
| methyl 3-(2-oxoethyl)benzoate | C10H10O3 | 124038-37-5 | Details |
| CCT6B Blocking Peptide | Details |
| 1-N,6-Dimethylbenzene-1,2-diamine | C8H12N2 | 73902-65-5 | Details |
| H-Gln(Trt)-2-chlorotrityl resin (200-400 mesh) (Low Substitution) | Details |
| 2H-Indazole | C7H6N2 | 271-42-1 | Details |
| 3,4'-Dihydroxy-7-methoxyflavone | 84638-53-9 | Details |
| 3-Bromo-5-chloro-4-nitropyridine | C5H2BrClN2O2 | 1335057-82-3 | Details |
| FKBP3 antibody | Details |
| tert-Butyl N-(1-carbamimidoylethyl)carbamate hydrochloride | C8H18ClN3O2 | 1330180-06-7 | Details |
| Sulfaclozine sodium monohydrate | C10H12ClN4NaO3S | 1392129-96-2 | Details |
| Pannexin-1 Fragment (4512) | Details |
| MIER3 Blocking Peptide | Details |
| 4-{[2-(2-Chlorophenyl)-2-(1H-indol-3-yl)ethyl]sulfamoyl}benzoic acid | C23H19ClN2O4S | 1053106-28-7 | Details |
| DDAH1 Blocking Peptide | Details |
| 8-Oxa-1-azaspiro[4.5]decane hydrochloride | C8H16ClNO | 1427378-94-6 | Details |
| 1-[(2-Methyl-1,3-thiazol-5-yl)methyl]piperazine | C9H15N3S | 1250118-20-7 | Details |
| 2,3-Dihydro-1,4-benzodioxine-6,7-diamine | C8H10N2O2 | 81927-47-1 | Details |
| PF 00835231 | C24H32N4O6 | 870153-29-0 | Details |
| LDB3 Blocking Peptide | Details |
| Dexamethasone Impurity A | Details |
| N-[2-(Phenylsulfanyl)phenyl]formamide | C13H11NOS | 1489-24-3 | Details |
| 1-Pyrimidin-2-yl-pyrrolidin-3-ol | C8H11N3O | 1261229-76-8 | Details |
| Salireposide | C20H22O9 | 16955-55-8 | Details |
| 2-Cyclopropyl-2-phenylacetic acid | C11H12O2 | 5689-18-9 | Details |
| Dog RBC antibody (Texas Red) | Details |
| cRel antibody (Ser503) | Details |
| 5-(2-Fluorovinyl)-2'-Deoxyuridine | 80015-51-6 | Details |
| Ethyl 7-chloro-8-fluoro-4-hydroxyquinoline-3-carboxylate | C12H9ClFNO3 | 75001-54-6 | Details |
| Nicomol | C34H32N4O9 | 27959-26-8 | Details |
| H-Lys-Leu-OH acetate salt | C14H29N3O5 | 103404-72-4 | Details |
| 3-[2-(Trifluoromethyl)phenyl]piperazin-2-one | C11H11F3N2O | 1246551-30-3 | Details |
| MAGEA10 Blocking Peptide | Details |
| MAL-dPEG?4-Lys(t-Boc)-NH-m-dPEG?24 | Details |
| 3-[(1-Carbamoylpropyl)carbamoyl]propanoic acid | C8H14N2O4 | 716341-76-3 | Details |
| tert-Butyl 4-cyano-2,2,5-trimethyl-1,3-oxazolidine-3-carboxylate | C12H20N2O3 | 1334149-56-2 | Details |
| rac-[(2R,3R)-1-Cyclopropyl-2-(1-methyl-1H-imidazol-5-yl)piperidin-3-yl]methanol | C13H21N3O | 1969288-14-9 | Details |
| Myogenin antibody | Details |
| GRP78 antibody (C-terminus) | Details |
| 3-(3,5-Dichlorophenyl)-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid | C24H19Cl2NO4 | 188814-26-8 | Details |
| 2-(4-Hydroxypiperidin-1-yl)benzoic acid hydrochloride | C12H16ClNO3 | 2377034-22-3 | Details |
| 3-Bromo-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one | C5H3BrN4O | 20419-67-4 | Details |
| Diproxadol | C12H14ClNO4 | 52042-24-7 | Details |
| 2-{3,5-Dioxo-10-oxa-4-azatricyclo[5.2.1.0,2,6]decan-4-yl}propanoic acid | C11H13NO5 | 154902-09-7 | Details |
| 4-(4-Ethylpiperazin-1-yl)-2-methoxyaniline dihydrochloride | C13H22ClN3O | 1803570-62-8 | Details |
| RAPGEF1 Blocking Peptide | Details |
| 2-amino-1-(1-aza-2-(3-pyridyl)vinyl)ethene-1,2-dicarbonitrile | C10H7N5 | 58259-74-8 | Details |
| 1-(Aminomethyl)-3,3-dimethylcyclohexan-1-ol hydrochloride | C9H20ClNO | 911010-82-7 | Details |
| Methyl 2-hydroxy-2-(oxan-2-yl)acetate | 2103418-78-4 | Details |
| (2R)-2,3-Diaminopropan-1-ol dihydrochloride | C3H11ClN2O | 87584-93-8 | Details |
| Product Total： Product Page： | ||||
| 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 | ||||